TY - JOUR
T1 - Coronary Atherosclerotic Precursors of Acute Coronary Syndromes
AU - Chang, Hyuk Jae
AU - Lin, Fay Y.
AU - Lee, Sang Eun
AU - Andreini, Daniele
AU - Bax, Jeroen
AU - Cademartiri, Filippo
AU - Chinnaiyan, Kavitha
AU - Chow, Benjamin J.W.
AU - Conte, Edoardo
AU - Cury, Ricardo C.
AU - Feuchtner, Gudrun
AU - Hadamitzky, Martin
AU - Kim, Yong Jin
AU - Leipsic, Jonathon
AU - Maffei, Erica
AU - Marques, Hugo
AU - Plank, Fabian
AU - Pontone, Gianluca
AU - Raff, Gilbert L.
AU - van Rosendael, Alexander R.
AU - Villines, Todd C.
AU - Weirich, Harald G.
AU - Al'Aref, Subhi J.
AU - Baskaran, Lohendran
AU - Cho, Iksung
AU - Danad, Ibrahim
AU - Han, Donghee
AU - Heo, Ran
AU - Lee, Ji Hyun
AU - Rivzi, Asim
AU - Stuijfzand, Wijnand J.
AU - Gransar, Heidi
AU - Lu, Yao
AU - Sung, Ji Min
AU - Park, Hyung Bok
AU - Berman, Daniel S.
AU - Budoff, Matthew J.
AU - Samady, Habib
AU - Shaw, Leslee J.
AU - Stone, Peter H.
AU - Virmani, Renu
AU - Narula, Jagat
AU - Min, James K.
N1 - Publisher Copyright:
© 2018
PY - 2018/6/5
Y1 - 2018/6/5
N2 - Background: The association of atherosclerotic features with first acute coronary syndromes (ACS) has not accounted for plaque burden. Objectives: The purpose of this study was to identify atherosclerotic features associated with precursors of ACS. Methods: We performed a nested case-control study within a cohort of 25,251 patients undergoing coronary computed tomographic angiography (CTA) with follow-up over 3.4 ± 2.1 years. Patients with ACS and nonevent patients with no prior coronary artery disease (CAD) were propensity matched 1:1 for risk factors and coronary CTA–evaluated obstructive (≥50%) CAD. Separate core laboratories performed blinded adjudication of ACS and culprit lesions and quantification of baseline coronary CTA for percent diameter stenosis (%DS), percent cross-sectional plaque burden (PB), plaque volumes (PVs) by composition (calcified, fibrous, fibrofatty, and necrotic core), and presence of high-risk plaques (HRPs). Results: We identified 234 ACS and control pairs (age 62 years, 63% male). More than 65% of patients with ACS had nonobstructive CAD at baseline, and 52% had HRP. The %DS, cross-sectional PB, fibrofatty and necrotic core volume, and HRP increased the adjusted hazard ratio (HR) of ACS (1.010 per %DS, 95% confidence interval [CI]: 1.005 to 1.015; 1.008 per percent cross-sectional PB, 95% CI: 1.003 to 1.013; 1.002 per mm3 fibrofatty plaque, 95% CI: 1.000 to 1.003; 1.593 per mm3 necrotic core, 95% CI: 1.219 to 2.082; all p < 0.05). Of the 129 culprit lesion precursors identified by coronary CTA, three-fourths exhibited <50% stenosis and 31.0% exhibited HRP. Conclusions: Although ACS increases with %DS, most precursors of ACS cases and culprit lesions are nonobstructive. Plaque evaluation, including HRP, PB, and plaque composition, identifies high-risk patients above and beyond stenosis severity and aggregate plaque burden.
AB - Background: The association of atherosclerotic features with first acute coronary syndromes (ACS) has not accounted for plaque burden. Objectives: The purpose of this study was to identify atherosclerotic features associated with precursors of ACS. Methods: We performed a nested case-control study within a cohort of 25,251 patients undergoing coronary computed tomographic angiography (CTA) with follow-up over 3.4 ± 2.1 years. Patients with ACS and nonevent patients with no prior coronary artery disease (CAD) were propensity matched 1:1 for risk factors and coronary CTA–evaluated obstructive (≥50%) CAD. Separate core laboratories performed blinded adjudication of ACS and culprit lesions and quantification of baseline coronary CTA for percent diameter stenosis (%DS), percent cross-sectional plaque burden (PB), plaque volumes (PVs) by composition (calcified, fibrous, fibrofatty, and necrotic core), and presence of high-risk plaques (HRPs). Results: We identified 234 ACS and control pairs (age 62 years, 63% male). More than 65% of patients with ACS had nonobstructive CAD at baseline, and 52% had HRP. The %DS, cross-sectional PB, fibrofatty and necrotic core volume, and HRP increased the adjusted hazard ratio (HR) of ACS (1.010 per %DS, 95% confidence interval [CI]: 1.005 to 1.015; 1.008 per percent cross-sectional PB, 95% CI: 1.003 to 1.013; 1.002 per mm3 fibrofatty plaque, 95% CI: 1.000 to 1.003; 1.593 per mm3 necrotic core, 95% CI: 1.219 to 2.082; all p < 0.05). Of the 129 culprit lesion precursors identified by coronary CTA, three-fourths exhibited <50% stenosis and 31.0% exhibited HRP. Conclusions: Although ACS increases with %DS, most precursors of ACS cases and culprit lesions are nonobstructive. Plaque evaluation, including HRP, PB, and plaque composition, identifies high-risk patients above and beyond stenosis severity and aggregate plaque burden.
KW - acute coronary syndrome
KW - atherosclerosis
KW - clinical outcome
KW - coronary artery disease
KW - coronary computed tomography angiography
UR - http://www.scopus.com/inward/record.url?scp=85047161744&partnerID=8YFLogxK
U2 - 10.1016/j.jacc.2018.02.079
DO - 10.1016/j.jacc.2018.02.079
M3 - Article
C2 - 29852975
AN - SCOPUS:85047161744
SN - 0735-1097
VL - 71
SP - 2511
EP - 2522
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
IS - 22
ER -